Severe COVID-19 is defined primarily by how well your lungs can deliver oxygen to your body. The key marker is a blood oxygen level that drops low enough to require supplemental oxygen, particularly high-flow oxygen or ventilation support. Most people with COVID-19 experience mild to moderate illness, but roughly 10 to 15 percent of symptomatic cases progress to the severe category, where the body’s inflammatory response begins to damage the lungs and potentially other organs.
How Severe COVID-19 Is Classified
The World Health Organization uses a 0-to-10 clinical progression scale to categorize COVID-19 outcomes. Severe disease starts at a score of 6, which corresponds to hospitalization with high-flow oxygen or non-invasive ventilation. The levels above that, scores 7 and 8, involve mechanical ventilation (a breathing tube) with or without medications to support blood pressure. A score of 9 means the patient needs the most advanced life support, and 10 is death.
In practical terms, doctors separate hospitalized patients into three groups based on what kind of breathing support they need: those who don’t need supplemental oxygen, those on standard oxygen or non-invasive ventilation, and those who require a breathing tube and mechanical ventilation. Moving into that second or third group is what tips a case from moderate to severe or critical.
There’s also a distinction between “severe” and “critical.” Severe cases typically involve significant breathing difficulty and low oxygen levels that develop quickly. Critical cases go further: respiratory failure that doesn’t respond to standard oxygen therapy, septic shock, or failure of multiple organs including the kidneys, liver, or heart.
When Symptoms Typically Turn Serious
COVID-19 doesn’t usually become severe overnight. The disease follows a fairly predictable timeline. Most people arrive at the hospital around day 4 after their first symptoms appear. Mild breathing difficulty tends to show up around day 5. By day 7 or 8, patients who are going to develop serious respiratory distress usually do, and acute respiratory distress syndrome (a condition where the lungs fill with fluid) tends to appear around day 9. For those who ultimately need a breathing tube, that typically happens about 10 days after hospitalization.
This window between days 7 and 10 is the critical period. The initial phase of COVID-19 feels like a bad flu, with fever, cough, and body aches. The second phase is driven by the immune system’s inflammatory response, which can spiral out of control and damage lung tissue faster than the body can repair it. That’s why someone might feel like they’re improving around day 5 or 6, then deteriorate rapidly over the next 48 hours.
What Doctors Look for in Blood Tests and Imaging
Several blood markers help doctors gauge how severe a case is becoming. C-reactive protein (CRP), which measures inflammation, is one of the most reliable. In patients who survived severe COVID-19, median CRP values were around 40 mg/L. In those who didn’t survive, the median was roughly 125 mg/L, more than three times higher.
D-dimer, a marker of blood clotting activity, is another strong predictor. Levels above 1 microgram per liter were the strongest independent predictor of death in early studies. Ferritin, a protein that stores iron, also rises sharply in severe cases and signals that the immune system’s inflammatory cascade has intensified to dangerous levels. Elevated ferritin points to what’s sometimes called a “cytokine storm,” where the immune response itself becomes the primary threat.
Chest CT scans offer a visual picture of severity. Radiologists score lung involvement across 20 different regions, assigning points based on how much of each region shows cloudy patches (opacification). The total score ranges from 0 to 40. A score above 19.5 identifies severe COVID-19 with 83 percent sensitivity and 94 percent specificity, meaning it correctly flags most severe cases while rarely misidentifying mild ones.
Who Is Most Likely to Develop Severe Disease
Your baseline health before infection is the strongest predictor of whether COVID-19 will become severe. The CDC identifies a long list of conditions that raise the risk: cancer, diabetes (type 1 or type 2), chronic kidney disease at any stage, chronic lung disease, heart conditions, liver disease, and a weakened immune system from any cause including HIV, organ transplants, or immunosuppressive medications.
Body weight plays a significant role. The risk of severe illness climbs sharply with higher BMI. Overweight (BMI of 25 to 29.9), obesity (BMI of 30 to 39.9), and severe obesity (BMI of 40 or higher) each carry progressively greater risk. Neurological conditions including dementia, mental health conditions, substance use disorders, current or former smoking, and pregnancy also increase vulnerability. People with disabilities that limit mobility or lung function face elevated risk as well.
How Severe Cases Are Treated
Corticosteroids are the foundation of treatment for severe COVID-19. Dexamethasone is the most commonly used, and it’s one of the few treatments shown to reduce the risk of death in severe cases. It works by dialing down the overactive immune response that causes so much of the lung damage.
Beyond steroids, doctors may add medications that target specific parts of the inflammatory process. These include drugs that block a signaling molecule called IL-6, which fuels inflammation, or drugs that interrupt the cellular pathways that amplify the immune response. These are typically reserved for patients whose inflammation markers, particularly CRP, are elevated and rising despite steroid treatment. For critically ill patients on mechanical ventilation, the treatment approach shifts: antiviral medications are generally not started at that late stage, since the problem is no longer the virus itself but the body’s reaction to it.
Recovery Timeline for Severe Cases
Recovery from COVID-19 takes longer than most people expect, even for non-severe cases. In a large population study from Australia, only 20 percent of all confirmed cases had recovered within 10 days of getting sick. By 30 days, 80 percent had recovered. By two months, 91 percent. And by three months, 93 percent. That still leaves roughly 7 percent of people dealing with lingering symptoms beyond 90 days.
For hospitalized patients specifically, the timeline stretches further. The most commonly reported lingering symptoms were cough (affecting about 47 percent of those who hadn’t fully recovered at their last follow-up) and fatigue (36 percent). Compared to influenza, where most people bounce back within one to two weeks, COVID-19’s recovery period is substantially longer and less predictable.
People who required mechanical ventilation face the longest road back. Beyond the lung damage from the virus itself, weeks of sedation and immobility lead to significant muscle loss, and many patients need physical rehabilitation to regain basic functions like walking and climbing stairs. Full recovery can take months, and some degree of reduced lung capacity may persist for a year or more.